Literature DB >> 21080806

A new understanding in the epidemiology of melanoma.

Esther Erdei1, Salina M Torres.   

Abstract

The incidence of melanoma is continuing to increase worldwide. UV exposure is a known risk factor for melanoma. Geographic location is known to influence UV exposure and the distribution of the incidence of melanoma. Furthermore, epidemiologic data suggest that gender and genetics may influence the distribution of melanoma on the body surface and histopathologic characteristics of the lesion. This article describes what is known about the impact of gender, ethnicity and geography on the progression of melanoma. Advanced-stage cutaneous melanoma has a median survival time of less than 1 year. Surgical removal, radiotherapy, chemotherapy, targeted therapies and a variety of immunotherapies have been utilized in the treatment of melanoma. Current treatment strategies and the results of recent clinical trials are also discussed in this article.

Entities:  

Mesh:

Year:  2010        PMID: 21080806      PMCID: PMC3074354          DOI: 10.1586/era.10.170

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  110 in total

1.  Long-term survival in patients with metastatic melanoma treated with DTIC or temozolomide.

Authors:  Christina Kim; Christopher W Lee; Laurel Kovacic; Amil Shah; Richard Klasa; Kerry J Savage
Journal:  Oncologist       Date:  2010-06-10

2.  Site distribution of different types of skin cancer: new aetiological clues.

Authors:  S Franceschi; F Levi; L Randimbison; C La Vecchia
Journal:  Int J Cancer       Date:  1996-07-03       Impact factor: 7.396

Review 3.  Immunotherapy of melanoma.

Authors:  Peter Hersey
Journal:  Asia Pac J Clin Oncol       Date:  2010-03       Impact factor: 2.601

Review 4.  Melanoma incidence trends.

Authors:  Caroline Bevona; Arthur J Sober
Journal:  Dermatol Clin       Date:  2002-10       Impact factor: 3.478

5.  Melanoma and lifetime UV radiation.

Authors:  Cam C Solomon; Emily White; Alan R Kristal; Thomas Vaughan
Journal:  Cancer Causes Control       Date:  2004-11       Impact factor: 2.506

6.  CTLA-4 blockade: therapeutic potential in cancer treatments.

Authors:  Ahmad A Tarhini; Fatima Iqbal
Journal:  Onco Targets Ther       Date:  2010-06-24       Impact factor: 4.147

7.  Dynamic infrared imaging of cutaneous melanoma and normal skin in patients treated with BNCT.

Authors:  G A Santa Cruz; J Bertotti; J Marín; S J González; S Gossio; D Alvarez; B M C Roth; P Menéndez; M D Pereira; M Albero; L Cubau; P Orellano; S J Liberman
Journal:  Appl Radiat Isot       Date:  2009-03-28       Impact factor: 1.513

8.  Hormonal and reproductive influences and risk of melanoma in women.

Authors:  M A Smith; J A Fine; R L Barnhill; M Berwick
Journal:  Int J Epidemiol       Date:  1998-10       Impact factor: 7.196

9.  Estrogen receptor expression in cutaneous melanoma: a real-time reverse transcriptase-polymerase chain reaction and immunohistochemical study.

Authors:  Vincenzo de Giorgi; Carmelo Mavilia; Daniela Massi; Alessia Gozzini; Palma Aragona; Annalisa Tanini; Serena Sestini; Milena Paglierani; Vieri Boddi; Maria Luisa Brandi; Torello Lotti
Journal:  Arch Dermatol       Date:  2009-01

10.  Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma.

Authors:  Nancy E Thomas; Sharon N Edmiston; Audrey Alexander; Robert C Millikan; Pamela A Groben; Honglin Hao; Dawn Tolbert; Marianne Berwick; Klaus Busam; Colin B Begg; Dianne Mattingly; David W Ollila; Chiu Kit Tse; Amanda Hummer; Julia Lee-Taylor; Kathleen Conway
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-05       Impact factor: 4.254

View more
  83 in total

1.  Pathobiological properties of the ubiquitin ligase Nedd4L in melanoma.

Authors:  Yusuke Kito; Juncheng Bai; Naoe Goto; Hiroshi Okubo; Yoshihiro Adachi; Tomoko Nagayama; Tamotsu Takeuchi
Journal:  Int J Exp Pathol       Date:  2013-10-31       Impact factor: 1.925

2.  Spatio-temporal Bayesian model selection for disease mapping.

Authors:  R Carroll; A B Lawson; C Faes; R S Kirby; M Aregay; K Watjou
Journal:  Environmetrics       Date:  2016-09-28       Impact factor: 1.900

Review 3.  Capsule endoscopy for management of small bowel melanoma-is it time yet?

Authors:  Emilia Prakoso; Warwick S Selby
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-10

4.  Current evidences on the XPG Asp1104His polymorphism and melanoma susceptibility: a meta-analysis based on case-control studies.

Authors:  Yuanzhi Xu; Guangjun Jiao; Li Wei; Ning Wang; Yajun Xue; Jin Lan; Yajie Wang; Chuan Liu; Meiqing Lou
Journal:  Mol Genet Genomics       Date:  2014-09-18       Impact factor: 3.291

Review 5.  Nanomedicine in the application of uveal melanoma.

Authors:  Shuo You; Jing Luo; Hans E Grossniklaus; Ma-Ling Gou; Ke Meng; Qing Zhang
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

6.  Mycobacterium indicus pranii (Mw) inhibits invasion by reducing matrix metalloproteinase (MMP-9) via AKT/ERK-1/2 and PKCα signaling: A potential candidate in melanoma cancer therapy.

Authors:  Kuntal Halder; Sayantan Banerjee; Sweta Ghosh; Anamika Bose; Shibali Das; Bidisha Paul Chowdhury; Subrata Majumdar
Journal:  Cancer Biol Ther       Date:  2015-09-21       Impact factor: 4.742

7.  Moringa oleifera fruit induce apoptosis via reactive oxygen species-dependent activation of mitogen-activated protein kinases in human melanoma A2058 cells.

Authors:  Tae Eun Guon; Ha Sook Chung
Journal:  Oncol Lett       Date:  2017-05-31       Impact factor: 2.967

8.  Apoptosis and injuries of heavy ion beam and x-ray radiation on malignant melanoma cell.

Authors:  Jin Qin; Sha Li; Chao Zhang; Dong-Wei Gao; Qiang Li; Hong Zhang; Xiao-Dong Jin; Yang Liu
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

9.  Clinicopathological characteristics of vascular endothelial growth factor expression in uveal melanoma: A meta-analysis.

Authors:  Meng Yang; Xiaocong Kuang; Yanbin Pan; Meile Tan; Binzhu Lu; Jian Lu; Qiumei Cheng; Jianmin Li
Journal:  Mol Clin Oncol       Date:  2014-01-22

10.  The potential effect of patulin on mice bearing melanoma cells: an anti-tumour or carcinogenic effect?

Authors:  Manel Boussabbeh; Intidhar Ben Salem; Karima Rjiba-Touati; Chedy Bouyahya; Fadwa Neffati; Mohamed Fadhel Najjar; Hassen Bacha; Salwa Abid-Essefi
Journal:  Tumour Biol       Date:  2015-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.